January 20, 2021
Healthcare Distribution Alliance (HDA) President and CEO Chester “Chip” Davis, Jr., issued the following statement.
Healthcare Distribution Alliance – Patients Move Us.
SEARCH
News
FEATURED NEWS
Sean Spears of Eisai Honored With 2021 Nexus Award for Lifetime Achievement
November 17, 2021
The HDA Research Foundation recognized Sean Spears of Eisai, Inc., with the 2021 Nexus Award for Lifetime Achievement last night at the Thirteenth Annual CEO Roundtable Fundraiser in Washington, D.C. The...
HDA Statement on FDA Commissioner Nominee Dr. Robert Califf
November 12, 2021
Healthcare Distribution Alliance (HDA) President and CEO Chester “Chip” Davis, Jr., released the following statement regarding President Biden’s nomination of Dr. Robert Califf as FDA Commissioner.
HDA Foundation Survey Reveals Uneven Progress on Rx Product Serialization, with 2023 DSCSA Requirements Around the Corner
November 1, 2021
The pharmaceutical supply chain’s progress on implementing product serialization requirements to comply with the Drug Supply Chain Security Act (DSCSA) has slowed as the November 2023 deadline for compliance...
-
HDA Statement on Biden-Harris Inauguration
-
HDA Statement on Biden Administration COVID-19 Relief and Vaccine Distribution PlanJanuary 16, 2021
HDA President and CEO Chester “Chip” Davis, Jr., released a statement following President-elect Biden’s introduction of a COVID-19 vaccination plan.
-
HDA Research Foundation Names Supply Chain ScholarsJanuary 13, 2021
The HDA Research Foundation has conferred four graduate-level scholarships to pharmaceutical supply chain leaders.
-
HDA Statement on COVID-19 Emergency Relief PackageDecember 22, 2020
HDA President and CEO Chester “Chip” Davis, Jr., released a statement commenting on passage of the COVID-19 emergency relief package by the U.S. House of Representatives and the U.S. Senate.
-
HDA Statement on FDA Authorization of Moderna VaccineDecember 18, 2020
HDA President and CEO Chester “Chip” Davis, Jr., released a statement following the U.S. Food and Drug Administration’s (FDA) granting of an Emergency Use Authorization for the Moderna COVID-19 vaccine candidate.
Media Contacts
